Literature DB >> 16787202

The application of Freidinger lactams and their analogs in the design of conformationally constrained peptidomimetics.

Andrej Perdih1, Danijel Kikelj.   

Abstract

Peptides exist in solution as an equilibrium mixture of conformers. The backbone conformational constraints are of interest as a means of limiting degrees of freedom and thereby constraining a synthetic peptide into the bioactive conformation. This concept plays an important role in the design of peptidomimetics in the drug development process. In the early eighties, Freidinger proposed the concept of protected lactam-bridged dipeptides, which was a milestone in the design of conformationally constrained peptides. These types of compounds, now widely known as Freidinger lactams, have been of interest to many medicinal and peptide chemists. This review seeks to present the various applications that Freidinger lactams and their hetero-, fused- and unsaturated analogs have found in the design of conformationally constrained peptidomimetics in different therapeutic areas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787202     DOI: 10.2174/092986706777442066

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  3 in total

1.  Post-Translational Backbone Engineering through Selenomethionine-Mediated Incorporation of Freidinger Lactams.

Authors:  Dillon T Flood; Nicholas L Yan; Philip E Dawson
Journal:  Angew Chem Int Ed Engl       Date:  2018-06-11       Impact factor: 15.336

2.  Modified Synthesis of the Peptidomimetic Natriuretic Peptide Receptor-C Antagonist M372049.

Authors:  Jacob D Porter; Sergey V Lindeman; Chris Dockendorff
Journal:  Tetrahedron Lett       Date:  2020-01-22       Impact factor: 2.415

3.  Solid-phase synthesis of tetrahydropyridazinedione-constrained peptides.

Authors:  Chang Won Kang; Sujeewa Ranatunga; Matthew P Sarnowski; Juan R Del Valle
Journal:  Org Lett       Date:  2014-10-08       Impact factor: 6.005

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.